Lemborexant
ATC N05CJ02 · 7 markets · 14 records
AU 3 records · 3 strengths
- 10 mgtabletDAYVIGO lemborexant 5 mg film coated tablet blister pack
- 5 mgtabletDAYVIGO lemborexant 5 mg film coated tablet blister pack
Records without a stated strength · 1 DAYVIGO
US 2 records · 2 strengths
CA 2 records · 2 strengths
SG 2 records · 2 strengths
TW 2 records · 2 strengths
HK 2 records · 1 strengths
Records without a stated strength · 1 DAYVIGO
MX 1 records · 1 strengths
Records without a stated strength · 1 DAYVIGO
| Strength / form / release | US | CA | AU | SG | MX | TW | HK |
|---|---|---|---|---|---|---|---|
| 10 mg tablet | DAYVIGO | DAYVIGO | DAYVIGO lemborexant 5 mg film coated tablet blister pack | DAYVIGO | DAYVIGO 達衛眠錠10毫克 | ||
| 5 mg tablet | DAYVIGO | DAYVIGO | DAYVIGO lemborexant 5 mg film coated tablet blister pack | DAYVIGO | DAYVIGO 達衛眠錠5毫克 | ||
unknown | DAYVIGO | DAYVIGO | |||||
tablet | DAYVIGO |
Scroll horizontally for more markets →
Each country column shows the locally registered trade names — not translations.
1 more strength/form rows are recorded only in MX and are not shown in this table. Hay 1 filas de concentración/forma registradas solo en MX que no se muestran en esta tabla. 另有 1 个规格/剂型仅在 MX 有记录(未在本表显示)。 另有 1 個規格/劑型僅在 MX 有記錄(未在本表顯示)。
“not disclosed” means the source does not publish the strength — it does not mean the product has none.
Hong Kong records are name/ingredient-level only: no strength, dosage form or registration status; on the register does not prove current supply.
Australia ARTG data has no registration-status column, so status is shown as unknown; being on the register does not mean currently marketed.
Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.